Back

Bail-out glycoprotein IIb/IIIa inhibitors for coronary microvascular obstruction: guideline-indicated, but does harm outweigh benefit?

European Heart Journal

1 September 2024
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY CORONARY ARTERY DISEASE, ACUTE CORONARY SYNDROMES, ACUTE CARDIAC CARE Acute Coronary Syndromes IMAGING Cardiac Magnetic Resonance (CMR) Interventional Cardiology

Contributors

Jasmine Latter
Jasmine Latter

Author

Peter J McCartney
Peter J McCartney

Author

Colin Berry
Colin Berry

Author

University of Glasgow Glasgow , United Kingdom of Great Britain & Northern Ireland

You may be interested in
thumbnail
Congress Presentation
The impact of primary percutaneous coronary intervention strategies during st-elevation myocardial infarction on the prevalence of coronary microvascular dysfunction
27 August 2023
thumbnail
Webinar
Prevention of heart failure post-acute myocardial infarction
12 January 2021
thumbnail
Congress Session
State-of-the-art antithrombotic treatment in acute coronary syndromes: a paradigm shift?
14 March 2025
thumbnail
Congress Presentation
Inhibition of fractalkine signalling reduces intramyocardial haemorrhage and left ventricular thrombus in patients with acute myocardial infarction by modulating immunothrombosis (The FRACTAL trial)
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources